pSivida to raise $US16m

08/01/2016 - 12:32

Bookmark

Save articles for future reference.

US-focused biotech company pSivida has released pricing details of a $US16 million capital raising, after two weeks of volatile trading in its ASX-listed shares.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options